The retinoprotective role of phenytoin
- PMID: 30410309
- PMCID: PMC6198895
- DOI: 10.2147/DDDT.S169621
The retinoprotective role of phenytoin
Abstract
Phenytoin is a non-sedative barbiturate derivate and has been recently rediscovered as a neuroprotective and retinoprotective compound in patients affected by optic neuritis secondary to multiple sclerosis. However, currently there are still no neuroprotective compounds registered and available in the clinic. We reviewed the literature supporting the retinoprotective properties of phenytoin and analyzed the various approaches and definitions from the first research periods onwards. The retinoprotective role of phenytoin was already known in the 1970s, but only recently has this effect been rediscovered, confirming that it could indeed provide structural protection of the retinal cells.
Keywords: multiple sclerosis; neuroprotection; optic neuritis; phenytoin; retinoprotection.
Conflict of interest statement
Disclosure The authors report no conflicts of interest in this work.
References
-
- Willmore LJ. Antiepileptic drugs and neuroprotection: current status and future roles. Epilepsy Behav. 2005;7(Suppl. 3):S25–S28. - PubMed
-
- Grimm C, Hermann DM, Bogdanova A, et al. Neuroprotection by hypoxic preconditioning: HIF-1 and erythropoietin protect from retinal degeneration. Semin Cell Dev Biol. 2005;16(4–5):531–538. - PubMed
-
- Farkas RH, Grosskreutz CL. Apoptosis, neuroprotection, and retinal ganglion cell death: an overview. Int Ophthalmol Clin. 2001;41(1):111–130. - PubMed
-
- Silverstein FS, Buchanan K, Hudson C, Johnston MV. Flunarizine limits hypoxia-ischemia induced morphologic injury in immature rat brain. Stroke. 1986;17(3):477–482. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
